PT  - JOURNAL ARTICLE
AU  - Sophie Khettar
AU  - Sophie Jacquin Courtois
AU  - Jacques Luaute
AU  - Evelyne Decullier
AU  - Sylvie Bin
AU  - Marine Dupuis
AU  - Laurent Derex
AU  - Laura Mechtouff
AU  - Norbert Nighoghossian
AU  - Claude Dussart
AU  - Gilles Rode
AU  - Audrey Janoly-Dumenil
TI  - Multiprofessional intervention to improve adherence to medication in stroke patients: a study protocol for a randomised controlled trial (ADMED AVC study)
AID  - 10.1136/ejhpharm-2020-002425
DP  - 2022 May 01
TA  - European Journal of Hospital Pharmacy
PG  - 169--175
VI  - 29
IP  - 3
4099  - http://ejhp.bmj.com/content/29/3/169.short
4100  - http://ejhp.bmj.com/content/29/3/169.full
SO  - Eur J Hosp Pharm2022 May 01; 29
AB  - Introduction Adherence to secondary preventive medications is often suboptimal in patients with stroke, exposing them to an increased risk of recurrent cerebral and/or cardiovascular events. Effective actions in the long term to improve adherence to medication are needed. The study will evaluate the efficacy of a collaborative multiprofessional patient-centred intervention conducted by a pharmacist on adherence to secondary preventive medication in stroke survivors.Methods and analysis This is a multicentre cluster-randomised controlled trial. Two groups of 91 patients (intervention vs standard care) will be recruited. The clinical pharmacist intervention targeting secondary preventive medication will consist of three parts over 1 year: (1) an individual semi-structured interview at hospital discharge; (2) follow-up telephone interviews at 3, 6 and 9 months after discharge; and (3) a final individual semi-structured interview 1 year after discharge. Information on patient follow-up will be shared with the general practitioner and the community pharmacist by sending a report of each interview. The primary outcome is adherence to medication during the 12 months after hospital discharge, assessed using a composite endpoint: the medication possession ratio associated with a self-administered questionnaire.Ethics and dissemination The local ethics committee, the national committee for use of personal data in medical research and the national data protection agency approved the study. The sponsor has no role in study design; collection, analysis and interpretation of data; or report writing.Discussion This pharmacist-led educational programme has the potential to significantly improve adherence to medication in stroke survivors which could lead to a decrease in recurrent cerebral and/or cardiovascular events.Trial registration number NCT02611440 There are no data in this work.